Responses
Clinical science
Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
Compose a Response to This Article
Other responses
No responses have been published for this article.